November 14, 2017
Wilson Therapeutics at Stora Aktiedagen Stockholm (Swedish)
October 25, 2017
Presentation of preliminary data from the ongoing extension period of the Phase 2 trial with WTX101 by Professor Michael L. Schilsky. Recording of webcast hosted by DNB.
August 28, 2017
Presentation of current treatments for Wilson Disease with a focus on novel treatment perspectives
April 24, 2017
Presentation of final Phase 2 data from the Phase 2 trial with WTX101 with Professor Karl Heinz Weiss. Recording of presentation held at the EASL meeting.